about
Emerging treatment options to improve cardiovascular outcomes in patients with acute coronary syndrome: focus on losmapimodThe case for inhibiting p38 mitogen-activated protein kinase in heart failureCardiomyocyte-Specific Human Bcl2-Associated Anthanogene 3 P209L Expression Induces Mitochondrial Fragmentation, Bcl2-Associated Anthanogene 3 Haploinsufficiency, and Activates p38 SignalingTissue-specific up-regulation of arginase I and II induced by p38 MAPK mediates endothelial dysfunction in type 1 diabetes mellitus.p38α regulates actin cytoskeleton and cytokinesis in hepatocytes during development and agingIdentification of cardiac-related circulating microRNA profile in human chronic heart failure.N-Methyl-D-Aspartate Receptor Signaling and Function in Cardiovascular TissuesHow cardiomyocytes sense pathophysiological stresses for cardiac remodeling.Approved and Experimental Small-Molecule Oncology Kinase Inhibitor Drugs: A Mid-2016 Overview.The p38 pathway, a major pleiotropic cascade that transduces stress and metastatic signals in endothelial cells.Redox-dependent dimerization of p38α mitogen-activated protein kinase with mitogen-activated protein kinase kinase 3.'Conditioning the heart' - lessons we have learned from the past and future perspectives for new and old conditioning 'drugs'.TAB1-induced auto-activation of p38α mitogen-activated protein kinase is crucially dependent on Threonine 185.Role of Molecular Interactions and Protein Rearrangement in the Dissociation Kinetics of p38α MAP Kinase Type-I/II/III Inhibitors.Effects of hypoestrogenism and/or hyperaldosteronism on myocardial remodeling in female mice
P2860
Q26798359-789F0583-914D-421E-B994-F1920FC74C22Q28080674-C9A1EC91-29F7-4C64-82FA-C0D15CFA7389Q28385823-CFC0C51A-2B4C-41A6-87AA-A759A090DC4FQ36124220-BDDB3EB6-75AF-4109-9E8F-8FD647C1FECDQ36271777-7DDD605A-6DA4-407F-8634-850AD69CF480Q36729339-87718189-8C17-4B74-92E1-0BE0D14BC99FQ38798614-14899E54-B5C7-4819-BF06-DB1FE5678A22Q38974621-4B1AB554-50CD-40B7-9CD5-920CA62BACA1Q38989374-49B70109-BBDD-412D-9E24-13B944B2BAD2Q41547499-14786B79-F28E-4B60-A1C6-F3F31A6009C3Q42285882-D6729727-5E32-427A-A524-3455F5C6321CQ43219124-266317BC-F23C-4D1A-B76B-42CB3573C4E7Q47305269-895A6034-DD47-45A7-908A-5A801D61660DQ52331082-40697E63-9977-45CE-9931-CDC885642697Q59126955-2161D453-B585-484D-B581-5459473A1F9C
P2860
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
p38 MAPK in cardioprotection - are we there yet?
@ast
p38 MAPK in cardioprotection - are we there yet?
@en
p38 MAPK in cardioprotection - are we there yet?
@nl
type
label
p38 MAPK in cardioprotection - are we there yet?
@ast
p38 MAPK in cardioprotection - are we there yet?
@en
p38 MAPK in cardioprotection - are we there yet?
@nl
prefLabel
p38 MAPK in cardioprotection - are we there yet?
@ast
p38 MAPK in cardioprotection - are we there yet?
@en
p38 MAPK in cardioprotection - are we there yet?
@nl
P2860
P921
P356
P1476
p38 MAPK in cardioprotection - are we there yet?
@en
P2093
P2860
P304
P356
10.1111/BPH.12901
P407
P577
2015-04-01T00:00:00Z